SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Microcide Pharmaceuticals (MCDE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (53)5/17/1997 9:57:00 PM
From: Czechsinthemail   of 186
 
Rick,

Thanks for your reply. Since this is much closer to your area of expertise, do you know anything from research results or the scientific literature to lend support to or detract from the different development approaches CBST and MCDE are taking? My understanding is that both companies have a strong science platform, but I'd appreciate any particulars you could add.

And if neither company has a product in clinical trials, do you have any information on how far along they are toward selecting lead compounds for clincals?

Since you've invested in MCDE but not in CBST, I'm curious about your preference for MCDE. Apart from the superior cash to market cap ratio, what have you found in MCDE that you like better?

Baird
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News